Adlercreutz H (1990) Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical and Laboratory Investigation 2011, 3–23.
Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T and Okada H (1991) Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. American Journal of Clinical Nutrition 54, 1093–1100.
Akazaki K and Stemmerman GN (1973) Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. Journal of the National Cancer Institute 50, 1137–1144.
Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M and Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry 262, 5592–5595.
Anderson DC (1974) Sex-hormone-binding globulin. Clinical Endocrinology 3, 69–96.
Anderson KE, Rosner W, Khan MS, New MI, Pang SY, Wissel PS and Kappas A (1987) Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in man. Life Sciences 40, 1761–1768.
Armstrong B and Doll R (1975) Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. International Journal of Cancer 15, 617–631.
Belanger A, Locong A, Noel C, Cusan L, Dupont A, Prevost J, Caron S and Sevigny J (1989) Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult men. Journal of Steroid Biochemistry 32, 829–833.
Brawley OW, Ford LG, Thompson I, Perlman JA and Kramer BS (1994) 5-Alpha-reductase inhibition and prostate cancer prevention. Cancer Epidemiology, Biomarkers, and Prevention 3, 177–182.
Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH and Tulinius H (1977) Latent carcinoma of prostate of autopsy in seven areas. International Journal of Cancer 20, 680–688.
Burke CW and Anderson DC (1972) Sex-hormone-binding globulin is an oestrogen amplifier. Nature 240, 38–40.
Cassidy A, Bingham S and Setchell KD (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. American Journal of Clinical Nutrition 60, 333–340.
Coffey DS and JRajfer (1986) Endocrine control of normal and abnormal growth of the prostate. In Urologic Endocrinology pp. 170-195 [Rajfer J, editor]. Philadelphia, PA: W.B. Saunders.
Coward L, Barnes NC, Setchell KDR and Barnes S (1993) The antitumor isoflavones, genistein and daidzein, in soybean foods of American and Asian diets. Journal of Agricultural and Food Chemistry 41, 1961–1967.
Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA, Campbell WS, Nair PP, Franz C, Kahle L and Taylor PR (1996) Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. American Journal of Clinical Nutrition 64, 850–855.
Dunn JF, Nisula BC and Rodbard D (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism 53, 58–68.
Eldridge AC (1982) Determination of isoflavones in soybean flours, protein concentrates, and isolates. Journal of Agricultural and Food Chemistry 30, 353–355.
Evans BA, Griffiths K and Morton MS (1995) Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. Journal of Endocrinology 147, 295–302.
Fleiss JL; (1986) The Design and Analysis of Clinical Experiments. New York: John Wiley and Sons.
Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R and Schweigerer L (1995) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Journal of Nutrition 125, 790S–797S.
Gann PH, Hennekens CH, Ma J, Longcope C and Stampfer MJ (1996) Prospective study of sex hormone levels and risk of prostate cancer. Journal of the National Cancer Institute 88, 1118–1126.
Gates JR, Parpia B, Campbell TC and Junshi C (1996) Association of dietary factors and selected plasma variables with sex hormone-binding globulin in rural Chinese women. American Journal of Clinical Nutrition 63, 22–31.
Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC and Willett WC (1993) A prospective study of dietary fat and risk of prostate cancer. Journal of the National Cancer Institute 85, 1571–1579.
Goldberg GR, Black AE, Jebb SA, Cole TJ, Murgatroyd PR, Coward WA and Prentice AM (1991) Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify under-recording. European Journal of Clinical Nutrition 45, 569–581.
Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan DE, Pappas F, Taylor A, Binkowitz B and Ng J (1992) The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. New England Journal of Medicine 327, 1185–1191.
Grulich AE, McCredie M and Coates M (1995) Cancer incidence in Asian migrants to New South Wales, Australia. British Journal of Cancer 71, 400–408.
Hamalainen E, Adlercreutz H, Puska P and Pietinen P (1984) Diet and serum sex hormones in healthy men. Journal of Steroid Biochemistry 20, 459–464.
Hammond GL (1978) Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues. Journal of Endocrinology 78, 7–19.
Horton R, Hawks D and Lobo R (1982) 3 alpha 17 beta-Androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism. Journal of Clinical Investigation 69, 1203–1206.
Hsing AW (1996) Hormones and prostate cancer: where do we go from here?. Journal of the National Cancer Institute 88, 1093–1095.
Hutchinson GB (1976) Epidemiology of prostatic cancer. Seminars in Oncology 3, 151–159.
Key TJ, Roe L, Thorogood M, Moore JW, Clark GM and Wang DY (1990) Testosterone, sex hormone-binding globulin, calculated free testosterone, and oestradiol in male vegans and omnivores. British Journal of Nutrition 64, 111–119.
Kinouchi T and Horton R (1974) 3 Alpha-androstanediol in human peripheral plasma. Journal of Clinical Endocrinology and Metabolism 38, 262–268.
Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS and Santen RJ (1991) Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. Journal of Clinical Endocrinology and Metabolism 72, 1242–1248.
Loukovaara M, Carson M, Palotie A and Adlercreutz H (1995) Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids 60, 656–661.
Mahoudeau JA, Bardin CW and Lipsett MB (1971) The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to 5α-androstanediols. Journal of Clinical Investigation 50, 1338–1344.
Meikle AW, Collier ES, Middleton RG and Fang SM (1980) Supranormal nuclear content of 5 alpha-dihydrotestosterone in benign hyperplastic prostate of humans. Journal of Clinical Endocrinology and Metabolism 51, 945–947.
Meikle AW and Stanish WM (1982) Familial prostatic cancer risk and low testosterone. Journal of Clinical Endocrinology and Metabolism 54, 1104–1108.
Mousavi Y and Adlercreutz H (1993) Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 58, 301–304.
Muir CS, Nectoux J and Staszewski J (1991) The epidemiology of prostatic cancer: Geographical distribution and time-trends. Acta Oncologica 30, 133–140.
Noble RL (1977) The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Research 37, 1929–1933.
Partin AW, Oesterling JE, Epstein JI, Horton R and Walsh PC (1991) Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. Journal of Urology 145, 405–409.
Peterson G and Barnes S (1993) Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22, 335–345.
Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M and Coward L (1996) Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiology, Biomarkers, and Prevention 5, 785–794.
Raben A, Kiens B, Richter EA, Rasmussen LB, Svenstrup B, Micic S and Bennett P (1992) Serum sex hormones and endurance performance after a lacto-ovo vegetarian and a mixed diet. Medicine and Science in Sports and Exercise 24, 1290–1297.
Reed MJ, Cheng RW, Simmonds M, Richmond W and James VH (1987) Dietary lipids: an additional regulator of plasma levels of sex hormone binding globulin. Journal of Clinical Endocrinology and Metabolism 64, 1083–1085.
Rittmaster RS, Zwicker H, Thompson DL, Konok G and Norman RW (1993) Androstanediol glucuronide production in human liver, prostate, and skin. Journal of Clinical Endocrinology and Metabolism 76, 977–982.
Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC and Henderson BE (1992) 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339, 887–889.
Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE and Mack TM (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. British Journal of Cancer 63, 963–966.
Shutt DA and Cox RI (1972) Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. Journal of Endocrinology 52, 299–310.
Sinclair AJ, O'Dea K, Dunstan G, Ireland PD and Niall M (1987) Effect on plasma lipids and fatty acid composition of very low fat diets enriched with fish or kangaroo meat. Lipids 1987, 523–529.
Slattery ML, Schumacher MC, West DW, Robison LM and French TK (1990) Food-consumption trends between adolescent and adult years and subsequent risk of prostate cancer. American Journal of Clinical Nutrition 52, 752–757.
Snowdon DA (1988) Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-day Adventists. American Journal of Clinical Nutrition 48, 739–748.
Talamini R, La Vecchia C, Decarli A, Negri E and Franceschi S (1986) Nutrition, social factors and prostatic cancer in a Northern Italian population. British Journal of Cancer 53, 817–821.
Wei H, Wei L, Frenkel K, Bowen R and Barnes S (1993) Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutrition and Cancer 20, 1–12.
Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, Teh C-T and Paffenberger RS (1995) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. Journal of the National Cancer Institute 87, 652–661.
Wilding G (1995) Endocrine control of prostate cancer. Cancer Survey 23, 43–62.
Yu H, Harris RE, Gao YT, Gao R and Wynder EL (1991) Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. International Journal of Epidemiology 20, 76–81.
Zaridze DG, Muir CS and McMichael AJ (1985) Diet and cancer: value of different types of epidemiological studies. Nutrition and Cancer 7, 155–166.
Zumoff B, Levin J, Strain GW, Rosenfeld RS, O'Connor J, Freed SZ, Kream J, Whitmore WS, Fukushima DK and Hellman L (1982) Abnormal levels of plasma hormones in men with prostate cancer: evidence toward a 'two-disease' theory. Prostate 3, 579–588.